文献速递白血病

成人B-ALL两个新的高危亚型:CDX2高表达与IDH1/2突变

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
PubMed 文献 · Blood · 2022-01-01

The genetic basis of leukemogenesis in adults with B-cell acute lymphoblastic leukemia (B-ALL) is largely unclear, and its clinical outcome remains unsatisfactory.…

要点

  • CDX2高表达亚型以CDX2高表达和1q染色体获得为特征,预后不良。
  • IDH1/2突变亚型由IDH1 R132C或IDH2 R140Q突变定义,伴特定转录和高甲基化谱。
  • 两亚型在AYA和成人中频率显著高于儿童,部分解释预后年龄差异。

核心结论

  • 研究描绘了成人B-ALL的遗传和转录组图谱,并鉴定出CDX2高表达和IDH1/2突变两个预测不良结局的新亚型。

研究设计与样本

  • 纳入15-39岁AYA(n=193)和40-64岁成人(n=161)Ph阴性B-ALL患者,进行整合转录组和遗传学分析以划分亚型。

主要发现

  • 323例RNA测序病例中278例(86.1%)被分入18个亚型,ZNF384亚型最常见(22.6%)。
  • CDX2高表达亚型占3.4%,以CDX2高表达和反复出现的1q染色体获得为特征。
  • IDH1/2突变亚型占1.9%,由IDH1 R132C或IDH2 R140Q突变定义,伴特定转录和高甲基化谱。
  • 两个新亚型均显示不良预后,且为独立于临床参数的劣后预后因素。
  • 与既往报道的儿童B-ALL队列(n=1003)相比,两亚型在AYA/成人中的频率显著更高。

关键数值与推荐

  • CDX2高表达亚型:CDX2高表达且反复出现1q染色体获得。
  • IDH1/2突变亚型:存在IDH1 R132C或IDH2 R140Q突变并伴特定转录和高甲基化谱。

临床怎么用

  • 对成人Ph阴性B-ALL可考虑识别CDX2高表达和IDH1/2突变亚型以进行预后分层。
  • 两亚型预后不良,提示需探索针对性治疗策略。

局限性

  • 摘要未提及研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The genetic basis of leukemogenesis in adults with B-cell acute lymphoblastic leukemia (B-ALL) is largely unclear, and its clinical outcome remains unsatisfactory. This study aimed to advance the understanding of biological characteristics, improve disease stratification, and identify molecular targets of adult B-ALL. Adolescents and young adults (AYA) (15 to 39 years old, n = 193) and adults (40 to 64 years old, n = 161) with Philadelphia chromosome-negative (Ph-) B-ALL were included in this study. Integrated transcriptomic and genetic analyses were used to classify the cohort into defined subtypes. Of the 323 cases included in the RNA sequencing analysis, 278 (86.1%) were classified into 18 subtypes. The ZNF384 subtype (22.6%) was the most prevalent, with 2 novel subtypes (CDX2-high and IDH1/2-mut) identified among cases not assigned to the established subtypes. The CDX2-high subtype (3.4%) was characterized by high expression of CDX2 and recurrent gain of chromosome 1q. The IDH1/2-mut subtype (1.9%) was defined by IDH1 R132C or IDH2 R140Q mutations with specific transcriptional and high-methylation profiles. Both subtypes showed poor prognosis and were considered inferior prognostic factors independent of clinical parameters. Comparison with a previously reported pediatric B-ALL cohort (n = 1003) showed that the frequencies of these subtypes were significantly higher in AYA/adults than in children. We delineated the genetic and transcriptomic landscape of adult B-ALL and identified 2 novel subtypes that predict poor disease outcomes. Our findings highlight the age-dependent distribution of subtypes, which partially accounts for the prognostic differences between adult and pediatric B-ALL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Yasuda T, Sanada M, Kawazu M, et al. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations. Blood. 2022. PMID: 34695176. doi:10.1182/blood.2021011921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。